Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ubiquitin”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Early research (Phase 1)Looking for participantsNCT06223542
What this trial is testing

Studying TAK-243 in Patients With Advanced Cancer

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmIndolent Non-Hodgkin Lymphoma+3 more
National Cancer Institute (NCI) 95
Not applicableLooking for participantsNCT06940232
What this trial is testing

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

Who this might be right for
Pediatric Traumatic Brain Injury
University of Nebraska 330
Not applicableStudy completedNCT06537713
What this trial is testing

Diagnostic Role of Serum Testican and Ubiquitin Levels in Patients With Head Trauma

Who this might be right for
Moderate Traumatic Brain InjuryTestican-1Ubiquitin
Kanuni Sultan Suleyman Training and Research Hospital 89
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Not applicableStudy completedNCT02834065
What this trial is testing

Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest

Who this might be right for
Cognition Disorders
Duke University 273
Early research (Phase 1)Ended earlyNCT02045095
What this trial is testing

A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Millennium Pharmaceuticals, Inc. 29
Not applicableStudy completedNCT00635440
What this trial is testing

Randomized, Controlled Study to Investigate the Effect of Neuromuscular Electrical Stimulation (NMES) on Muscle Metabolism of Abdominal Surgical Patients

Who this might be right for
Muscular Atrophy
Medical University of Vienna 26
Not applicableLooking for participantsNCT06449183
What this trial is testing

VIDAS® TBI Real Life Performance in Subjects with Mild Traumatic Brain Injury (mTBI)

Who this might be right for
Mild Traumatic Brain Injury
BioMérieux 900
Not applicableStudy completedNCT01358617
What this trial is testing

Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+2 more
Children's Oncology Group 90
Not applicableLooking for participantsNCT05885529
What this trial is testing

Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to Significant Traumatic Brain Injuries

Who this might be right for
Traumatic Brain Injury
Centre Hospitalier Princesse Grace 1,500
Early research (Phase 1)Study completedNCT00011778
What this trial is testing

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma
National Cancer Institute (NCI) 25
Not applicableUnknownNCT00819442
What this trial is testing

Relationship Between Abnormalities of Desmin Cytoskeleton, Mitochondrial Activity and Expression of Ubiquitin in Aspect of Pathogenesis of Heart Failure and Prognosis

Who this might be right for
Dilated Cardiomyopathy
Ministry of Scientific Research and Information Technology, Poland 60
Not applicableUnknownNCT02256241
What this trial is testing

The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin

Who this might be right for
Group 1: Trauma Operation for Otherwise Healthy PatientsGroup 2: Primary Tumors of Mesenchymal Origin
Rambam Health Care Campus 90
Testing effectiveness (Phase 2)Study completedNCT00216697
What this trial is testing

An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib Therapy

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 13
Not applicableEnded earlyNCT06581757
What this trial is testing

Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH

Who this might be right for
Subarachnoid Haemorrhage (SAH)
The Royal Wolverhampton Hospitals NHS Trust 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT06782373
What this trial is testing

Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

Who this might be right for
VEXASVEXAS Syndrome
Swedish Orphan Biovitrum 78